Outcomes of Patients with Clinical Stage I-IIIA Large-Cell Neuroendocrine Lung Cancer Treated with Resection

Large-cell neuroendocrine carcinoma (LCNEC) is a rare malignancy with poor prognosis. The rationale of the study was to determine the survival of LCNEC patients in I–IIIA clinical stages who underwent resection. A total of 53 LCNEC (89%) and combined LCNEC (11%) patients in stages I–IIIA who underwe...

Descripción completa

Detalles Bibliográficos
Autores principales: Lowczak, Anna, Kolasinska-Cwikla, Agnieszka, Ćwikła, Jarosław B, Osowiecka, Karolina, Palucki, Jakub, Rzepko, Robert, Glinka, Lidka, Doboszyńska, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290504/
https://www.ncbi.nlm.nih.gov/pubmed/32392725
http://dx.doi.org/10.3390/jcm9051370

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290504/
https://www.ncbi.nlm.nih.gov/pubmed/32392725
http://dx.doi.org/10.3390/jcm9051370

Ejemplares similares